| 厄贝沙坦氢氯噻嗪初始治疗2级高血压80例临床观察 |
| |
| 引用本文： | 亓维东,韩霞.厄贝沙坦氢氯噻嗪初始治疗2级高血压80例临床观察[J].哈尔滨医药,2011,31(1):2-3. |
| |
| 作者姓名： | 亓维东 韩霞 |
| |
| 作者单位： | 山东省莱芜市人民医院,山东,莱芜,271100 |
| |
| 摘 要： | 目的 评价厄贝沙坦氢氯噻嗪片初始治疗2级高血压的疗效及安全性.方法 采用自身对照,开放单一治疗试验设计方法,对80例新发2级高血压病人口服厄贝沙坦氢氯噻嗪片1片,4周时血压不达标则剂量加倍,观察8周,记录治疗前后诊所血压及24h动态血压的变化,观察不良反应,以评价疗效与安全 性.结果 厄贝沙坦氢氯噻嗪片治疗1周后血压即...
|
| 关 键 词： | 厄贝沙坦氢氯噻嗪片 高血压 初始治疗 |
Efficacy and Safety of Irbesartan/HCTZ Fixed-dose Combination as Initial Therapy for Moderate Hypertension |
| |
| QI Weidong,HAN Xia.Efficacy and Safety of Irbesartan/HCTZ Fixed-dose Combination as Initial Therapy for Moderate Hypertension[J].harbin medical journal,2011,31(1):2-3. |
| |
| Authors: | QI Weidong HAN Xia |
| |
| Institution: | QI Weidong,HAN Xia(The People's Hospital of Laiwu City,Laiwu 271100,China) |
| |
| Abstract: | Objective To study the efficacy and safety of irbesartan/HCTZ as initial therapy for moderate hypertension.Methods In this open,single therapy trial,the 80 cases of patients with moderate hypertention who were untreated before received fixed-dose irbesartan 150 mg/HCTZ 12.5 mg combination therapy for 8 weeks,one tablet of irbesartan(150 mg)/HCTZ(12.5 mg) once a day during the first 4 weeks.If blood pressure was greater than140/90 mm Hg at the end of the fourth week,two tablets of irbesartan(150 mg)/HCTZ(12.... |
| |
| Keywords: | Irbesartan/HCTZ Hypertension Initial therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
